Allogeneic Endothelial Progenitor Cells

endothelial progenitor cells · Allife Medical Science and Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic Endothelial Progenitor Cells, covering 2025-08-12 to 2025-08-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) in Patients With Acute Ischemic Stroke [Phase 1]

See pricing